katherineg2552

1
Revolade 75mg tablet Apple pharmaceuticals

• INDICATION
• DOSAGEMECHANISM
• ADMEPRECAUTION
• DRUG INTERACTION
• STORAGE
• MISSED DOSESIDE EFFECTS

2
Revolade 75mg tablet Apple pharmaceuticals

• Revolade 75mg is a prescription drug which is
  used under the supervision of the doctor.
• Revolade 75mg drug may be used as part of a
  co-administration therapy. Hence drug may require
  fortaking it with other medications.
• INDICATION
• Revolade 75mg tablet is mainly indicated for the
  treatment of patients having
• lower platelet levels due to chronic immune
  thrombocytopenia
• lower platelet counts due to chronic hepatitis
  C virus infection

3

•  

Revolade 75mg
4
DOSAGE

• Chronic Immune Thrombocytopenia
• The recommended dose of Revolade 75mg has
  Initial 50 mg PO qDay Adjust dose to achieve
  Control platelet count (Plt) gt50 x 109/L to
  reduces risk of bleeding not to exceed 75
  mg/day

Revolade 75mg
5

• Chronic Hepatitis C-associated Thrombocytopenia
• The recommended dose of Revolade 75mg has
  Initial 25 mg PO qDay Dose is Adjust in 25 mg
  accretion q2weeks PRN to attain target Plt needed
  to start/control antiviral therapy with pegylated
  interferon and ribavirin not to exceed 100
  mg/day During antiviral therapy, regulate dose to
  stop dose reductions of peginterferon Severe
  Aplastic Anemia
• First-line therapy Concomitant use with standard
  immunosuppressive therapy, for patients with
  serious aplastic Anemia (SAA) The recommended
  dose of Revolade 75mg tablet 150 mg PO qDay for
  6 months Do not give more than starting dose
  total duration is 6 months
• Refractory SAA
• The drug given for this condition who fail to
  respond enough to at least 1 before
  immunosuppressive therapy The recommended dose
  of Revolade 75mg 50 mg PO qDay Adjust dose in
  50-mg accretion q2Weeks PRN to attain target Plt
  50 x 109/L as required not exceed 150 mg/day
  may take up to 16 weeks for hematologic response.

6
MECHANISM

• Eltrombopag belongs to growth factors which
  excite platelet production through the
  thrombopoietin (TPO) receptor.  
• Eltrombopag is a thrombopoietin nonpeptide
  agonist which have high platelet counts by
  binding to and activating the TPO receptor. It
  stimulates pathways within the cell to raises the
  production and development of marrow progenitor
  (parent) cells to strengthen platelet production.

7
ADME

• Absorption
• peak plasma concentration is 2-6 hours
• Distribution
• highly human plasma protein bounding is gt99 and
  in blood plasma level is 50 to 79
• Metabolism
• predominantly metabolised through cleavage,
  oxidation and conjugation with glucuronic acid.
• Elimination
• Revolade 75mg eliminated primarily via feces 59,
  along with 31 via renally excreted
• Half-life of Revolade 75mg healthy patients is
  21-23 hours and idiopathic thrombocytopenic
  purpura is 26-35 hours.

8
PRECAUTION

• The drug causes warning condition call the doctor
  while new medication interaction If other blood
  clot risk factors, then avoid the drug because it
  will high level of platelet counts and blood
  clots.
• If the patients have cataracts, avoid the drug
  due to the drug effects cataracts and make the
  condition worse.
• Disease progression warning Avoid using the drug
  while the patients have myelodysplastic syndrome
  (MDS), will increases the risk of death.

9
DRUG INTERACTION

• Revolade 75mg co administration with these drugs
  ezetimibe, glyburide, Olmesartan, repaglinide,
  valsartan, imatinib, irinotecan, lapatinib,
  methotrexate, mitoxantrone, Bosentan,
  sulfasalazine, and topotecan irinotecan leads
  increase of side effects. hence the doctor may
  reduce your dosage of these drugs if required.
• Revolade 75mg tablet concomitant use with
  Cholesterol-reducing drugs like atorvastatin,
  fluvastatin, rosuvastatin, pravastatin, and
  simvastatin, pitavastatin. Have high side effects
  can contains muscle pain. The doctor may decrease
  the dosage of your cholesterol drugs.
• Revolade 75mg combination with Antacids,
  vitamins, or supplements which involves Ca, Al,
  Fe, Se, Zn, or Mg. To stop interactions, then
  take Revolade two hours before or four hours
  after administrating any of these products.

10

• STORAGE
• Store at room temperature 20C and 25C.
• Discard the left-out medicine if not used within
  30 minutes
• MISSED DOSE
• In case of missed dose, patients must consult
  with medical practitioner and follow the
  instructions given by them. thereby missed dose
  should be avoid and follow the regular dosing
  schedule.

11
SIDE EFFECTS

• Lack of appetite
• flu
• diarrhoea
• Urine in dark colour
• Yellowing of your skin
• low red blood cells
• nausea
• fever
• weakness
• pain in head
• cough

12

• Abdomen swelling
• Confusion
• Chest pain
• Dyspnea
• Cloudy vision
• Sensitivity to light
• Seeing circles around lights
• Swelling of legs

13
CONTACT DETAILS

• Phone  [phone]
• Email  applepharmaceutical_at_gmail.com
• Email  info_at_myapplepharma.com
• Website  https//myapplepharma.com/eltrombopag-75
  mg.php
•